Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

July 2026

Added to Dediabetes Jul 12, 2026Cohort

Dapagliflozin may improve RAAS markers in diabetes patients

This study investigated the effects of dapagliflozin on the renin-angiotensin-aldosterone system in patients with type 2 diabetes, finding significant changes in several metabolic parameters.

Interventions
Dapagliflozin
Outcomes
BMIDiastolic blood pressureFasting blood sugar (FBS)+8 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin improves brain function in type 2 diabetes

This study investigated the neuroprotective effects of dapagliflozin and liraglutide in patients with type 2 diabetes, highlighting distinct outcomes on brain function.

Interventions
DapagliflozinLiraglutide
Outcomes
Attention improvementMemory performanceOlfactory task functional connectivity+3 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin Improves Glycemic Control with Insulin Pump Therapy

This study evaluated the addition of dapagliflozin to insulin pump therapy in patients with Type 2 diabetes, finding significant improvements in glycemic targets and insulin dosage.

Interventions
Insulin therapyMetformin
Outcomes
Assessment of pancreatic function through insulin and C-peptide levelsTime to glycemic targetTotal daily insulin dose
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin improves metabolic outcomes in type 2 diabetes patients

This study compared the effects of dapagliflozin and vitamin E in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, finding significant improvements in several metabolic parameters with dapagliflozin.

Interventions
Dapagliflozin
Outcomes
ASTAlanine Aminotransferase (ALT)BMI+8 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin-linagliptin combo improves glycemic control and organ protection

This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.

Interventions
Dapagliflozin
Outcomes
Alanine Aminotransferase (ALT)Estimated glomerular filtration rateFasting Plasma Glucose (FPG)+5 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin shows no long-term harm to bone health in women with diabetes

This study investigated the effects of dapagliflozin on bone metabolism in post-menopausal women with type 2 diabetes, finding significant improvements in trabecular and cortical thickness.

Interventions
Dapagliflozin
Outcomes
Bone mineral density (BMD)Bone mineral density (BMD) at distal radiusBone mineral density (BMD) at femoral neck+7 more
Added to Dediabetes Jul 12, 2026RCTs

Daqing Diabetes Prevention Study II

The Daqing Diabetes Prevention Study II investigated the effectiveness of different lifestyle interventions on diabetes risk among adults in China. Results regarding the effectiveness of these interventions remain unclear.

Interventions
Complex lifestyle interventionDigital-based lifestyle interventionUsual care
Outcomes
BMIBlood glucoseDiabetes knowledge+4 more
Added to Dediabetes Jul 12, 2026RCTs

DASH diet improves sleep and mental health in women with diabetes

This study examined the impact of the DASH diet on sleep, mental health, and hormonal changes in Iranian women with Type 2 diabetes, revealing significant improvements in several health metrics.

Interventions
DASH diet
Outcomes
2-hour plasma glucoseAdvanced glycation end products (AGEs)Anxiety score+6 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.